Silo Pharma, Inc. (NASDAQ:SILO) Sees Significant Decline in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 130,600 shares, a decrease of 16.1% from the February 13th total of 155,700 shares. Currently, 3.0% of the shares of the company are short sold. Based on an average daily volume of 2,910,000 shares, the days-to-cover ratio is currently 0.0 days.

Silo Pharma Stock Performance

Shares of NASDAQ:SILO opened at $1.38 on Thursday. Silo Pharma has a 1-year low of $0.77 and a 1-year high of $4.50. The firm has a fifty day moving average price of $1.57 and a 200 day moving average price of $1.23.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.